RxDoctor Payments Data

Patrick Szaraz

Family · Miami, FLNPI 1215301890

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $287,915 of the $326,889 with a category attached, or 88.1%. AbbVie accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. 2025 is the largest year on record at $291,115, more than ten times the $791 reported in 2022. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$326,889in general payments, 2019–2025

Across 466 payments — averaging $701.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$327K
  • Galderma Laboratories, L.p.$16

What the payments were for

  • Speaking & faculty fees$287,91588%
  • Travel & lodging$31,94910%
  • Food & beverage$7,0252%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)465$326,872
Galderma Laboratories, L.p.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$326,889 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Other family in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →